4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzaldehyde(CAS: 2016-06-0)

This compound must adhere to the GHS classification, REACH regulations, and FDA/EPA requirements. It is classified as a hazardous substance due to its halogen content, which necessitates strict handling and storage protocols. Regulatory bodies require proper labeling, documentation, and safety measures to ensure safe use and disposal.

Alternatives to this compound include analogous iodinated compounds with different functional groups. Common substitutes in synthesis might involve using 4-(4-Hydroxyphenyl)-3,5-diiodobenzaldehyde or 4-(3,5-Diiodophenoxy)-3,5-diiodobenzaldehyde. These alternatives offer similar properties but with variations in reactivity and solubility.

Research trends for this compound are focused on its applications in medicinal chemistry and materials science. Recent studies have explored its potential in cancer therapeutics and as a precursor for advanced materials. Market demand is driven by these emerging research fields, with price trends reflecting increasing interest and demand in specialized chemical markets.

Waste containing this compound should be collected and stored in sealed containers to prevent leakage. Proper incineration or professional waste disposal methods are recommended. Environmental protection measures include ensuring all handling is conducted in a fume hood and following local regulations for hazardous waste management. Safe disposal is critical to avoid environmental contamination and ensure worker safety.